« Previous
Next »
American Journal of Kidney Diseases
Volume 52, Issue 4
, Pages 683-690
, October 2008
Risk Factors for Proteinuria in HIV-Infected and -Uninfected Hispanic Drug Users
References
- Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005;40:1559–1585
- . Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study. AIDS. 2004;18:541–546
- Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol. 2000;11:2079–2087
- Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med. 2002;8:522–526
- . HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro. Kidney Int. 1992;41:956–960
- . Natural history of heroin-associated nephropathy. N Engl J Med. 1974;290:19–23
- Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 1993;328:465–470
- Blood pressure control, proteinuria, and the progression of renal disease (The Modification of Diet in Renal Disease Study). Ann Intern Med. 1995;123:754–762
- . Proteinuria is a risk factor for mortality over 10 years of follow-up (MRFIT Research Group. Multiple Risk Factor Intervention Trial). Kidney Int Suppl. 1997;63:S10–S14
- . Proteinuria as a biomarker: Risk of subsequent morbidity and mortality. Environ Res. 1994;66:160–172
- Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777–1782
- . Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients. Clin Nephrol. 2004;61:1–6
- Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis. 2004;39:1199–1206
- . Dietary intake and body mass index in HIV-positive and HIV-negative drug abusers of Hispanic ethnicity. Public Health Nutr. 2004;7:863–870
- Population stratification confounds genetic association studies among Latinos. Hum Genet. 2006;118:652–664
- . MDRD Study Group: A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:155A;(abstr)
- Quantitative Insulin Sensitivity Check Index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402–2410
- Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr. 2003;32:203–209
- Microalbuminuria in HIV infection. AIDS. 2007;21:1003–1009
- . Nephrotic syndrome in drug addicts. N Y State J Med. 1974;74:92–95
- Nephrotic syndrome in heroin addicts. Lancet. 1972;1:17–20
- Renal involvement in drug abuse. Arch Intern Med. 1973;132:801–806
- . Heroin-associated nephropathy. Expert Opin Drug Saf. 2005;4:19–28
- . Drugs of abuse and renal disease. Curr Opin Nephrol Hypertens. 1996;5:122–126
- . Disappearance of uremia due to heroin-associated nephropathy. Am J Kidney Dis. 1995;25:689–693
- Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 2002;61:195–202
- Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: Another chain of link?. J Intern Med. 2006;260:255–262
- . Relationship between hepatitis C and microalbuminuria: Results from the NHANES III. Kidney Int. 2005;67:285–290
- . The role of hepatitis C virus infection in glomerulopathy. Hepatol Res. 2000;18:190–202
- . Relationship between hepatitis C and chronic kidney disease: Results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol. 2006;17:1168–1174
- . Increasing incidence of human immunodeficiency virus-associated nephropathy at San Francisco General Hospital. Am J Kidney Dis. 1991;18:655–659
- . Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients. Am J Kidney Dis. 2000;35:884–888
- . Course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med. 1989;87:389–395
- National Institutes of Health: Strategic Development and Planning Meeting Baseline Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney; 2001;
- . USRDS 2001 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney; 2001;
Because an author of this manuscript is an editor for AJKD, the peer-review and decision-making processes were handled entirely by an Associate Editor (Robert Nelson, MD, National Institutes of Health) who served as Acting Editor-in-Chief. Details of the journal's procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.
Originally published online as doi:10.1053/j.ajkd.2008.04.0161 on June 20, 2008.
PII: S0272-6386(08)00831-7
doi: 10.1053/j.ajkd.2008.04.016
© 2008 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
American Journal of Kidney Diseases
Volume 52, Issue 4
, Pages 683-690
, October 2008
